This site is intended for health professionals only
Friday 24 May 2019
Share |

Topic: Association News

December 15, 2017
The collaboration is centred on mRNA translation, which is a promising area of research with the potential to produce treatments that can target a fundamental characteristic of cancer cells

Cancer Research UK has announced the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology (CRT), and Celgene Corporation, to discover, develop and commercialise new anti-cancer treatments.


This arrangement represents an expansion of Cancer Research Technology’s theme-based translational model that now encompasses six industry partnerships, including this new collaboration with Celgene.  

November 30, 2017
Ann Page and Mark Borthwick will be co-Chairs of UKCPA for two years

At the UKCPA Conference on Saturday 25 November it was announced that Ann Page and Mark Borthwick will be co-Chairs of UKCPA for two years from 1 January 2018.


Mr Borthwick held the post of Chair from 2013 to 2015 and was supported by Ms Page as Vice-Chair during this time. Since May 2015 Ms Page has led the association as Chair, and Mr Borthwick has continued his involvement in the strategic direction of UKCPA as Immediate Past Chair.
 

November 30, 2017
At their annual Conference on 25 November 2017 the UKCPA celebrated two outstanding leaders in pharmacy

Mr Philip Howard, Consultant Pharmacist in Antimicrobials at Leeds Teaching Hospitals NHS Trust, was given the UKCPA Lifetime Achievement Award for 2017.
 

April 20, 2016
The UKCPA is delighted to receive a double accreditation from the Royal Pharmaceutical Society. The UKCPA is now an accredited Faculty Training Provider and Foundation Training Provider

The UKCPA is a much respected organisation which has a reputation for delivering high quality education and training to the pharmacy workforce, notably through its conferences and masterclasses.

December 10, 2015
2600 hospital pharmacies targeted with single set of clear information for patients

In the largest ever coordinated communication of its type, the British Generic Manufacturers Association (BGMA) has distributed patient information aimed at removing unnecessary duplication and improving impact when contacting pharmacists, GPs and other healthcare professionals about important safety information.
 

 

November 19, 2015
Goldberg and Cousins honoured by UKCPA

Laurie Goldberg and David Cousins were each presented with UKCPA Lifetime Achievement Awards at the UKCPA Autumn Symposium held in Leicester 13–14 November. The awards recognise their sustained contributions to clinical pharmacy.

 

October 29, 2015
Global awareness campaign calls for action to effect positive change for the many millions of people who live with psoriasis and psoriatic arthritis worldwide
October 9, 2015
During the 24th Congress of the European Academy of Dermatology and Venereology (EADV), the International Alliance of Dermatology Patient Organizations (IADPO) announced its official launch at the Patient Village of the Congress

During the 24th Congress of the European Academy of Dermatology and Venereology (EADV), the International Alliance of Dermatology Patient Organizations (IADPO) announced its official launch at the Patient Village of the Congress.

 

October 9, 2015
The increasing roles that pharmacists and their national associations are taking in mental health care are illustrated in a new document from FIP

The increasing roles that pharmacists and their national associations are taking in mental health care are illustrated in a new document from the International Pharmaceutical Federation (FIP). “Focus on mental health: The contribution of the pharmacist” is to be published tomorrow on World Mental Health Day.
 

 

September 30, 2015
The number of pharmacists per 10,000 population has grown around the world, according to a new report from the International Pharmaceutical Federation Education Initiative (FIPEd)

The publication, “Global pharmacy workforce intelligence: Trends report”, was released at the 75th World Congress of Pharmacy and Pharmaceutical Sciences. It is the fourth in a series of workforce reports produced every three years and contains a trend analysis of the three previous reports (2006, 2009, 2012), which covers 51 countries.
 

 

September 25, 2015
New report predicts learning together with other health professionals is becoming more mainstream

Learning together with other health professionals is becoming more mainstream for pharmacists and future pharmacists, according to a report published by the International Pharmaceutical Federation (FIP) Education Initiative.
 

September 24, 2015
Pharmacists everywhere are preparing to celebrate World Pharmacists Day on 25 September

Pharmacists everywhere are preparing to celebrate World Pharmacists Day. The International Pharmaceutical Federation (FIP) has heard about a variety of events being prepared by its member organisations. Belgium, for example, has organised a multidisciplinary symposium on therapeutic adherence. In the Philippines, poster and video-making contests as well as fitness activities such as Zumba dance will be held.

 

 

September 22, 2015
FIP produces Arabic pictograms to help refugees with their medicines

The global refugee crisis, particularly the nine million Syrians estimated to have fled their homes since 2011, has prompted the International Pharmaceutical Federation (FIP) to undertake urgent work to help pharmacists ensure that refugees who need medicines understand how to take them. An Arabic version of the FIP pictogram software has been released. FIP’s pictograms provide a means of communicating medication instructions when there is no common language or when patients have low literacy levels.
 

 

September 10, 2015
Global standards of practice used by hospital pharmacists around the world have been revised

Global standards of practice used by hospital pharmacists around the world have been revised and are released by the Hospital Pharmacy Section (HPS) of the International Pharmaceutical Federation (FIP).
 

The standards, known as the "Basel Statements” and first published by the HPS in 2009, cover six main areas of hospital pharmacy:
 

September 3, 2015
Global atrial fibrillation registry presents two-year outcomes data in more than 17,000 newly diagnosed AF patients The unique breadth and maturity of GARFIELD-AF Registry data presented at ESC Congress 2015 provides real-world insights on the evolution of managing AF in everyday clinical practice across the globe

The first-ever two-year outcomes from the Global Anticoagulant Registry in the Field – Atrial Fibrillation (GARFIELD-AF) showcased at ESC Congress 2015 expose that all-cause death was the most frequent major event in more than 17,000 newly diagnosed AF patients, far exceeding the rate of stroke or major bleeding. These two-year prospective outcomes from cohorts 1 and 2 show a mortality rate of 3.83% per person year compared to stroke rates of 1.25% per person year and major bleeding rates of 0.70% per person year. (1)       

August 19, 2015
Antibiotic Research UK will announce at its Annual General meeting its first research programme to tackle antibiotic resistant bacteria (superbugs)
July 31, 2015
News reports that scientists from the Cancer Research UK Cambridge Institute and Addenbrooke’s Hospital have discovered that there are five kinds of prostate cancer

News reports that scientists from the Cancer Research UK Cambridge Institute and Addenbrooke’s Hospital have discovered that there are five kinds of prostate cancer, the most common cancer among men in the UK. The study conducted by British scientists has found prostate cancer treatment could be transformed by the discovery that it is actually five different diseases.

July 1, 2015
The All Wales Medicine Strategy Group (AWMSG) has recommended brentuximab vedotin for restricted use in patients with relapsed or refractory CD30+ Hodgkin lymphoma after evaluating it through the new policy relating to ultra-orphan medicines

Takeda UK Ltd announced that brentuximab vedotin (Adcetris®) is the first medicine to be recommended for use in NHS Wales via the AWMSG’s new policy relating to ultra-orphan medicines. (1) Brentuximab vedotin has been recommended for restricted use for the treatment of adult patients with CD30+ relapsed or refractory Hodgkin lymphoma (HL) following an autologous stem cell transplant (ASCT) or following at least two previous therapies, when ASCT or multi-agent chemotherapy is not a treatment option. (1,2)

 

July 1, 2015
An important step towards the protection of healthcare workers and patients in situations of unrest was taken

An important step towards the protection of healthcare workers and patients in situations of unrest was taken when major global organisations for doctors, nurses and pharmacists adopted a set of new ethical principles.
 

 

June 12, 2015
Development of pharmacy education around the world through a unique collaboration between the International Pharmaceutical Federation (FIP), University College London School of Pharmacy and the United Nations Educational, Scientific and Cultural Organization (UNESCO) is to continue for a further four years.

Development of pharmacy education around the world through a unique collaboration between the International Pharmaceutical Federation (FIP), University College London School of Pharmacy and the United Nations Educational, Scientific and Cultural Organization (UNESCO) is to continue for a further four years.
 

June 8, 2015
New IntroDia™ Survey patient data was presented at American Diabetes Association’s® (ADA) 75th Scientific Sessions. IntroDia™ is an initiative of Boehringer Ingelheim and Lilly in partnership with the International Diabetes Federation.

New IntroDia™ Survey patient data was presented at American Diabetes Association’s®  (ADA) 75th Scientific Sessions. IntroDia™ is an initiative of Boehringer Ingelheim and Lilly in partnership with the International Diabetes Federation.

May 19, 2015
Data presented from the CDI Service Evaluation study shows that the adoption pattern of treatment impacts CDI outcomes. Compared to traditional broad-spectrum antibiotics, first-line use of fidaxomicin, a targeted treatment, in all CDI patients provides improved outcomes in terms of recurrence rate, all-cause mortality and cost effectiveness, compared to use in selected patients only. (8) CDI is associated with high-mortality (5,6,7) and cost burden, (9) therefore reducing the incidence and recurrence of CDI is a priority for clinicians, payers and health authorities alike.
May 18, 2015
In conjunction with the opening of the 68th World Health Assembly, the International Federation of Psoriasis Associations, IFPA, launches an issue brief on psoriatic arthritis, calling the international community to action.

In conjunction with the opening of the 68th World Health Assembly, the International Federation of Psoriasis Associations, IFPA, launches an issue brief on psoriatic arthritis, calling the international community to action.

May 14, 2015
Jim O’Neills Review on Antimicrobial Resistance launches their third interim report. Amongst the report’s recommendations is the creation of a $2 billion global fund to be spent over five years to assist organisations pay for their R&D on developing new antibiotics. Grants will be awarded from this fund, which will delink the reward side of antibiotic drug development from sales and should incentivise organisations to get back into the antibiotic development space. Global fund monies will be used to finance blue skies research into new antibiotics and diagnostics and encourage innovative partnerships at early development stages between academia and industry.

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?

Close

Respect for nurses: Sign up to our e-petition TODAY

The Nursing in Practice Respect campaign is now live! Over the coming months, we're set to highlight the vital contribution and efforts of primary care and community care nurses throughout the UK.

As part of our campaign, Nursing in Practice is looking to call on parliament to set up a debate to celebrate the vital work that you do.


GET INVOLVED: SIGN OUR E-PETITION

Close

Calling all primary care nurses! 'Like' our Nursing in Practice Facebook page to enter our free draw to win a £25 M&S voucher




http://www.facebook.com/NursinginPracticeMagazine